Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794351
Max Phase: Preclinical
Molecular Formula: C31H24O12
Molecular Weight: 588.52
Molecule Type: Unknown
Associated Items:
ID: ALA4794351
Max Phase: Preclinical
Molecular Formula: C31H24O12
Molecular Weight: 588.52
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc([C@H]2Oc3c(c(O)cc(O)c3[C@H]3C(=O)c4c(O)cc(O)cc4O[C@@H]3c3ccc(O)cc3)C(=O)[C@@H]2O)cc1O
Standard InChI: InChI=1S/C31H24O12/c1-41-20-7-4-13(8-16(20)34)30-28(40)27(39)24-19(37)11-18(36)23(31(24)43-30)25-26(38)22-17(35)9-15(33)10-21(22)42-29(25)12-2-5-14(32)6-3-12/h2-11,25,28-30,32-37,40H,1H3/t25-,28-,29+,30+/m0/s1
Standard InChI Key: GJWXCPDVDRIBKP-CNTBMXMRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 588.52 | Molecular Weight (Monoisotopic): 588.1268 | AlogP: 3.71 | #Rotatable Bonds: 4 |
Polar Surface Area: 203.44 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 7.34 | CX Basic pKa: | CX LogP: 4.50 | CX LogD: 4.11 |
Aromatic Rings: 4 | Heavy Atoms: 43 | QED Weighted: 0.18 | Np Likeness Score: 1.91 |
1. Hioki Y,Onwona-Agyeman S,Kakumu Y,Hattori H,Yamauchi K,Mitsunaga T. (2020) Garcinoic Acids and a Benzophenone Derivative from the Seeds of Garcinia kola and Their Antibacterial Activities against Oral Bacterial Pathogenic Organisms., 83 (7): [PMID:32644811] [10.1021/acs.jnatprod.9b01045] |
Source(1):